4.7 Article

Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 206, 期 13, 页码 2889-2896

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20090449

关键词

-

资金

  1. EICOSANOX [LSHM-CT-2004-005033]
  2. Deutsche Forschungsgemeinschaft (Exzellenzcluster 147 Cardio- Pulmonary Systems)
  3. Johann Wolfgang Goethe University

向作者/读者索取更多资源

Proline-rich tyrosine kinase 2 (PYK2) can be activated by angiotensin II (Ang II) and reactive oxygen species. We report that in endothelial cells, Ang II enhances the tyrosine phosphorylation of endothelial NO synthase (eNOS) in an AT(1)-, H2O2-, and PYK2-dependent manner. Low concentrations (1-100 mu mol/liter) of H2O2 stimulated the phosphorylation of eNOS Tyr657 without affecting that of Ser1177, and attenuated basal and agonist-induced NO production. In isolated mouse aortae, 30 mu mol/liter H2O2 induced phosphorylation of eNOS on Tyr657 and impaired acetylcholine-induced relaxation. Endothelial overexpression of a dominant-negative PYK2 mutant protected against H2O2-induced endothelial dysfunction. Correspondingly, carotid arteries from eNOS(-/-) mice overexpressing the nonphosphorylatable eNOS Y657F mutant were also protected against H2O2. In vivo, 3 wk of treatment with Ang II considerably increased levels of Tyr657-phosphorylated eNOS in the aortae of wild-type but not Nox2(y/-) mice, and this was again associated with a clear impairment in endothelium-dependent vasodilatation in the wildtype but not in the Nox2(y/-) mice. Collectively, endothelial PYK2 activation by Ang II and H2O2 causes the phosphorylation of eNOS on Tyr657, attenuating NO production and endothelium-dependent vasodilatation. This mechanism may contribute to the endothelial dysfunction observed in cardiovascular diseases associated with increased activity of the renin-angiotensin system and elevated redox stress.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据